Cravath, Weil Advise J&J On $480M Micrus Purchase
Under the agreement, J&J will pay $23.40 per share to Micrus stockholders. Micrus' share price jumped nearly 5 percent Monday, amid news of the acquisition.
Micrus, based in San Jose, Calif., develops and manufactures minimally invasive devices to treat hemorrhagic and ischemic stroke. It will join Codman & Shurtleff Inc., the neuro device unit of J&J subsidiary the DePuy...
To view the full article, register now.